Drug recall · February 12, 2020
Atorvastatin Calcium Tablets recall
Why: Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA; NDC 70377-027-11.
- Lots / codes
Lot #: ATA318099C, Exp 12/2020
- Quantity
- 29,056 bottles
- Company
- Graviti Pharmaceuticals Private Limited, Medak, N/A
- Distribution
- Nationwide in the USA.
- Initiated
- January 28, 2020 · Voluntary: Firm initiated
- Classified
- February 7, 2020
- Reported
- February 12, 2020
- Ended
- November 29, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atorvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.